Loss narrows and uptrend is bornLXRX moved above resistance and crossed its 50-day moving average.Next target SPlooks like $3
Lexicon Pharmaceuticals Inc. reported fourth quarter net loss of $12.2 million or $0.09 per share, compared to a net loss of $13.8 million or $0.19 per share in the previous year. Total revenues for the quarter declined to $13.8 million from $16.1 million in the prior year quarter.
On average, analysts polled by First Call/Thomson Financial expected loss of $0.12 share, while analysts estimated revenues of $10.02 million for the fourth quarter.
For fiscal 2007, net loss was $58.8 million or $0.59 per share, compared to a net loss of $54.3 million or $0.81 per share in the last year.
Total revenues for the year were $50.1 million, down from $72.8 million in the year-ago.